Skip to main content

Jeff Lagasse

By Jeff Lagasse | 11:58 am | November 11, 2022
The VillageMD deal includes investments from Walgreens Boots Alliance and Cigna subsidiary Evernorth.
By Jeff Lagasse | 03:25 pm | November 10, 2022
Elevance says the acquisition will help it meet the specialty drug needs of its customers with a whole-health approach.
By Jeff Lagasse | 11:52 am | November 10, 2022
Costs more than offset revenue gains, with total direct expense per provider climbing 9% from the year prior, reaching more than $626,000.
By Jeff Lagasse | 03:35 pm | November 09, 2022
The AG's office alleges the PBM was paid for drugs for workers' compensation claims that were in excess of what's allowed under state law.
By Jeff Lagasse | 12:39 pm | November 09, 2022
Substitution of costly generics with lesser-cost ones could generate great savings, Johns Hopkins says.
By Jeff Lagasse | 04:13 pm | November 08, 2022
Evidence shows that cross-market hospital systems raise prices by exerting power across markets when negotiating with insurers.
By Jeff Lagasse | 10:30 am | November 08, 2022
Nearly four in five Americans said virtual primary care allowed them to take charge of their health, the survey showed.
By Jeff Lagasse | 03:14 pm | November 07, 2022
A report uncovered unscrupulous advertising practices, including misleading beneficiaries about benefits and excessive cold-calling.
By Jeff Lagasse | 12:00 pm | November 07, 2022
The letter was spurred in part by a flood of respiratory illnesses, mental health crises and other needs that have strained resources and capacity.
By Jeff Lagasse | 03:40 pm | November 04, 2022
Concerns about a recession and runaway inflation only exacerbate the issue, impacting the ability to hire and retain top talent.